MEND offers an exciting new model of global healthcare delivery
Led by a highly experienced "first-in-class" team from the pharma and biotechnology industry
Seeks to create both economic and social value, but with priority placed on maximizing access to medicines that prevent amputation and death over financial gain
Blends the best practices and operating principles of pharmaceutical and nonprofit organizations
Employs a flexible, low cost corporate structure that minimizes administrative costs
Seeks to minimize healthcare disparities and injustice by providing care to all patients, irrespective of socioeconomic status
Prices products in line with patients' willingness and ability to pay
Redeploys revenues generated from these products to sustain MEND's mission and promote lasting social change
How are we different from traditional for-profit pharma companies?
We will provide access to life-saving medicines in all commercial markets across the socioeconomic spectrum, including the 80% of patients who pay for their medicines out of pocket. Maximizing access to affordable medicines means we price our products according to willingness and ability of patients to pay.This unique non-profit approach places patient health first and foremost over corporate financial gain.